Federal officials announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug, according to a report by PBS NewsHour. The announcement was made on Thursday, the report said. The item is credited to Matthew Perrone of The Associated Press.

PBS NewsHour described ibogaine as "championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump." Its headline referred to PTSD research funding for the drug.

ABC News reported that the Trump administration "will fund new research" on ibogaine, in a story linked from its own site at ABC News. Its summary described the drug only as a powerful psychedelic, and the item lists no author.

The two reports differ in emphasis. ABC News framed the announcement as research funding in general, while PBS NewsHour framed it as PTSD research funding and tied the drug to veterans, conservative lawmakers and podcasters aligned with President Donald Trump. ABC News's summary does not name those groups.

Neither the ABC News summary nor the PBS NewsHour summary gives the amount of the funding, the agency that will distribute it, the design of the research, or a timeline. Neither names the officials who made the announcement, and neither describes any medical findings about ibogaine so far. This account is based on the headlines and summaries of the two reports.

Sources: ABC News: Trump administration will fund new research on controversial psychedelic drug ibogaine; PBS NewsHour: WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogaine.